Maravai Lifesciences Holdings (MRVI) Other financing activities (2020 - 2026)

Maravai Lifesciences Holdings' Other financing activities history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.

• In Q1 2026, Other financing activities fell 9.21% year-over-year to -$3.9 million; the TTM figure through Mar 2026 stood at $1.0 million (down 68.86% YoY), while the FY2025 annual figure was $1.4 million, down 85.19% from the prior year.
• Other financing activities for Q1 2026 stood at -$3.9 million, down from $4.9 million in the prior quarter.
• The five-year high for Other financing activities was $4.9 million in Q2 2025, with the low at -$4.2 million in Q4 2023.
• The 5-year median for Other financing activities is $1.3 million (2022), against an average of $460285.7.
• The sharpest annual moves came in 2024 and 2025: Other financing activities soared 383.33% in 2024, then sank 248.86% in 2025.
• Maravai Lifesciences Holdings' Other financing activities stood at -$2.0 million in 2022, then plunged by 110.59% to -$4.2 million in 2023, then soared by 153.01% to $2.2 million in 2024, then soared by 120.9% to $4.9 million in 2025, then tumbled by 178.66% to -$3.9 million in 2026.
• Business Quant data shows MRVI's Other financing activities at -$3.9 million in Q1 2026, $4.9 million in Q2 2025, and -$3.5 million in Q1 2025.